WO2012078004A3 - 발효차 추출물을 포함하는 지질 수준 감소용 조성물 - Google Patents
발효차 추출물을 포함하는 지질 수준 감소용 조성물 Download PDFInfo
- Publication number
- WO2012078004A3 WO2012078004A3 PCT/KR2011/009502 KR2011009502W WO2012078004A3 WO 2012078004 A3 WO2012078004 A3 WO 2012078004A3 KR 2011009502 W KR2011009502 W KR 2011009502W WO 2012078004 A3 WO2012078004 A3 WO 2012078004A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- lipid level
- tea extracts
- fermented tea
- reducing lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Plant Substances (AREA)
- Tea And Coffee (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/992,412 US20130259855A1 (en) | 2010-12-09 | 2011-12-09 | Composition comprising fermented tea extracts for reducing lipid level |
CN201180065562.9A CN103327995B (zh) | 2010-12-09 | 2011-12-09 | 用于降低脂质水平的包含发酵茶提取物的组合物 |
EP11847685.2A EP2650005A4 (en) | 2010-12-09 | 2011-12-09 | COMPOSITION WITH FERMENTED TEA EXTRACTS FOR LIPID MIRROR REDUCTION |
JP2013543105A JP6066919B2 (ja) | 2010-12-09 | 2011-12-09 | 発酵茶抽出物を含む脂質水準減少用組成物 |
US15/074,588 US20160213731A1 (en) | 2010-12-09 | 2016-03-18 | Composition comprising fermented tea extracts for reducing lipid level |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100125468A KR101838588B1 (ko) | 2010-12-09 | 2010-12-09 | 발효차 추출물을 포함하는 지질 수준 감소용 조성물 |
KR10-2010-0125468 | 2010-12-09 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/992,412 A-371-Of-International US20130259855A1 (en) | 2010-12-09 | 2011-12-09 | Composition comprising fermented tea extracts for reducing lipid level |
US15/074,588 Division US20160213731A1 (en) | 2010-12-09 | 2016-03-18 | Composition comprising fermented tea extracts for reducing lipid level |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012078004A2 WO2012078004A2 (ko) | 2012-06-14 |
WO2012078004A3 true WO2012078004A3 (ko) | 2012-09-27 |
Family
ID=46207625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/009502 WO2012078004A2 (ko) | 2010-12-09 | 2011-12-09 | 발효차 추출물을 포함하는 지질 수준 감소용 조성물 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20130259855A1 (ko) |
EP (1) | EP2650005A4 (ko) |
JP (1) | JP6066919B2 (ko) |
KR (1) | KR101838588B1 (ko) |
CN (1) | CN103327995B (ko) |
WO (1) | WO2012078004A2 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017003204A1 (ko) * | 2015-06-30 | 2017-01-05 | (주)아모레퍼시픽 | 후발효차 추출물을 포함하는 신경 세포 보호용 조성물 |
JP6961339B2 (ja) * | 2015-12-18 | 2021-11-05 | アサヒ飲料株式会社 | 微生物菌体含有飲料 |
KR102418100B1 (ko) * | 2016-10-18 | 2022-07-08 | (주)아모레퍼시픽 | 신규한 퀘르세틴계 화합물을 포함하는 인지기능 개선용 조성물 |
KR20190047873A (ko) | 2017-10-30 | 2019-05-09 | (주)아모레퍼시픽 | 특정 성분 함량이 증가된 차 추출물을 포함하는 지방대사 이상의 예방 및 개선용 조성물 |
KR20190124579A (ko) * | 2018-04-26 | 2019-11-05 | 주식회사 비엔에이치리서치 | 보이차 추출물을 유효성분으로 포함하는 노화로 인한 인지기능 장애 예방 또는 치료용 약제학적 조성물 |
CN112042781A (zh) * | 2020-10-22 | 2020-12-08 | 厦门鹰君药业有限公司 | 铁皮石斛保健茶及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090170185A1 (en) * | 2005-09-08 | 2009-07-02 | Kabushiki Kaisha Yakult Honsha | Cholesterol absorption inhibitor |
KR20100091393A (ko) * | 2009-02-10 | 2010-08-19 | 계명대학교 산학협력단 | 콜레스테롤 및 지질대사 개선을 위한 식품 |
KR20100122296A (ko) * | 2009-05-12 | 2010-11-22 | (주)아모레퍼시픽 | 발효차를 함유하는 혈액 순환 개선용 조성물 및 이를 포함하는 약제학적 및 건강 식품 조성물 |
KR20100124519A (ko) * | 2009-05-19 | 2010-11-29 | (주)아모레퍼시픽 | 녹차 추출물을 함유하는 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100378545B1 (ko) * | 2000-07-29 | 2003-04-03 | 김정규 | 혈당 및 콜레스테롤 저하용 녹차된장 및 그 제조방법 |
KR100625829B1 (ko) * | 2004-09-06 | 2006-09-20 | 김동원 | 녹차청국장 및 그 제조방법 |
ES2348064T3 (es) * | 2005-02-23 | 2010-11-29 | Otsuka Pharmaceutical Co., Ltd. | Bebida de té fermentada y bebida de té. |
WO2007019526A2 (en) * | 2005-08-05 | 2007-02-15 | Naturegen, Inc. | Compositions and methods for controlling glucose and lipid uptake from foods |
JP4701328B2 (ja) * | 2006-02-02 | 2011-06-15 | 長崎県 | 発酵茶葉およびその製造方法、発酵茶葉抽出物ならびに飲食品 |
JP4705983B2 (ja) * | 2006-04-26 | 2011-06-22 | 株式会社 伊藤園 | 脂質吸収阻害剤 |
KR100816957B1 (ko) * | 2006-07-07 | 2008-03-27 | 순천대학교 산학협력단 | 녹차와 유용미생물을 이용한 기능성 발효녹차미생물제 및 그 제조방법과 그것을 이용한 돼지의 사육방법과 그로부터 얻어진 돈육 |
CN101283712B (zh) * | 2008-04-30 | 2011-10-12 | 晶旺生物科技股份有限公司 | 接菌发酵的普洱茶制法 |
JP5576386B2 (ja) * | 2008-11-25 | 2014-08-20 | アモーレパシフィック コーポレイション | バチルス属菌株を用いた発酵茶の製造方法 |
KR101698919B1 (ko) * | 2009-10-15 | 2017-01-23 | (주)아모레퍼시픽 | 발효차 추출물을 함유하는 혈액 순환 개선 및 수족 냉증 개선용 조성물 |
-
2010
- 2010-12-09 KR KR1020100125468A patent/KR101838588B1/ko active IP Right Grant
-
2011
- 2011-12-09 US US13/992,412 patent/US20130259855A1/en not_active Abandoned
- 2011-12-09 JP JP2013543105A patent/JP6066919B2/ja active Active
- 2011-12-09 EP EP11847685.2A patent/EP2650005A4/en not_active Ceased
- 2011-12-09 WO PCT/KR2011/009502 patent/WO2012078004A2/ko active Application Filing
- 2011-12-09 CN CN201180065562.9A patent/CN103327995B/zh active Active
-
2016
- 2016-03-18 US US15/074,588 patent/US20160213731A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090170185A1 (en) * | 2005-09-08 | 2009-07-02 | Kabushiki Kaisha Yakult Honsha | Cholesterol absorption inhibitor |
KR20100091393A (ko) * | 2009-02-10 | 2010-08-19 | 계명대학교 산학협력단 | 콜레스테롤 및 지질대사 개선을 위한 식품 |
KR20100122296A (ko) * | 2009-05-12 | 2010-11-22 | (주)아모레퍼시픽 | 발효차를 함유하는 혈액 순환 개선용 조성물 및 이를 포함하는 약제학적 및 건강 식품 조성물 |
KR20100124519A (ko) * | 2009-05-19 | 2010-11-29 | (주)아모레퍼시픽 | 녹차 추출물을 함유하는 조성물 |
Non-Patent Citations (3)
Title |
---|
J.-K. LIN ET AL.: "Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols", MOLECULAR NUTRITION & FOOD RESEARCH, vol. 50, 2006, pages 211 - 217, XP009152926 * |
PV A. BABU ET AL.: "Green tea extract impedes dyslipidemia and development of cardiac dysfunction in streptozotocin-diabetic rats", CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, vol. 33, 2006, pages 1184 - 1189, XP055110887 * |
See also references of EP2650005A4 * |
Also Published As
Publication number | Publication date |
---|---|
KR20120064299A (ko) | 2012-06-19 |
JP6066919B2 (ja) | 2017-01-25 |
US20160213731A1 (en) | 2016-07-28 |
JP2014503515A (ja) | 2014-02-13 |
WO2012078004A2 (ko) | 2012-06-14 |
KR101838588B1 (ko) | 2018-03-16 |
CN103327995A (zh) | 2013-09-25 |
CN103327995B (zh) | 2016-05-04 |
EP2650005A2 (en) | 2013-10-16 |
US20130259855A1 (en) | 2013-10-03 |
EP2650005A4 (en) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012078004A3 (ko) | 발효차 추출물을 포함하는 지질 수준 감소용 조성물 | |
WO2011142618A3 (ko) | 미량의 진세노사이드 성분이 증가된 신규한 가공인삼 또는 가공인삼추출물의 제조방법 | |
WO2013032189A3 (ko) | 발효 식물성 오일 및 이를 포함하는 조성물 | |
WO2011127409A3 (en) | Methods and compositions related to fatty alcohol biosynthetic enzymes | |
WO2010000877A3 (en) | Formulation with irritation reducing action comprising bisabolol and [6]-paradol | |
WO2008085221A3 (en) | Therapeutic use of cd31 expressing cells | |
WO2010112494A3 (de) | Mischgetränk | |
WO2010151541A8 (en) | Polymorphic form d of bazedoxifene acetate and methods of preparing same | |
WO2011098582A3 (en) | Novel crystalline forms of ivabradine hydrochloride | |
WO2010049454A3 (en) | Antimicrobial composition from copepods | |
WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
AU2018256621A1 (en) | A melloed rose brew and process for preparation thereof | |
EA201490624A1 (ru) | Ферменты | |
WO2014206419A3 (en) | Compositions comprising fermented seaweed and/or algae | |
WO2012140075A3 (en) | Method for production of brewers wort | |
WO2011093686A3 (ko) | 쿠메스트롤 생산 방법 및 그에 의해 생산된 쿠메스트롤 | |
WO2012049307A3 (en) | Novel n-terminally modified insulin derivatives | |
MX355768B (es) | Nuevas composiciones de masa madre y métodos para su preparación. | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2011159129A3 (ko) | 신규한 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 aids 예방 또는 치료용 약학 조성물 | |
WO2012142302A3 (en) | Biocatalytic process for preparing eslicarbazepine and analogs thereof | |
WO2011057006A3 (en) | Insecticidal fermentation broth from actinomycetes | |
CL2013001842A1 (es) | Preparacion de enzimas obtenidas desde la fermentacion de koji, la cual comprende hongos fermentados con aspergillus; proceso de produccion; y su uso. | |
WO2011135581A3 (en) | Pharmaceutical compositions of dronedarone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180065562.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11847685 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2013543105 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13992412 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2011847685 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011847685 Country of ref document: EP |